問卷

TPIDB > Search Result

Search Result

篩選

List

19Cases

2021-10-01 - 2027-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2021-03-31 - 2025-01-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting3Sites

Terminated1Sites

2026-02-23 - 2032-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2019-12-01 - 2025-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2023-10-17 - 2028-12-31

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2023-01-05 - 2026-09-30

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2018-03-18 - 2024-10-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2018-03-01 - 2020-12-29

Phase I/II

An Open-Label Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
  • Condition/Disease

    Advanced Stage Newly Diagnosed Hodgkin Lymphoma

  • Test Drug

    ADCETRIS

Participate Sites
2Sites

Recruiting1Sites

Terminated1Sites

2014-04-30 - 2023-04-16

Phase III

Safety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B
  • Condition/Disease

    Haemophilia B

  • Test Drug

    N9-GP

Participate Sites
2Sites

Recruiting2Sites

1 2